Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

Table of Contents

March 01, 2023; Volume 384,Issue 3

Viewpoint

  • You have access
    Paving the Way for Cancer Therapy a Nano Step at a Time
    Divya Venkatesh and Taha Merghoub
    Journal of Pharmacology and Experimental Therapeutics March 2023, 384 (3) 327-330; DOI: https://doi.org/10.1124/jpet.122.001514
  • Open Access
    Pharmacodynamic and Antitumor Activity of BI 836880, a Dual Vascular Endothelial Growth Factor and Angiopoietin 2 Inhibitor, Alone and Combined with Programmed Cell Death Protein-1 Inhibition
    Irmgard Hofmann, Anke Baum, Marco H. Hofmann, Francesca Trapani, Claudia Reichel-Voda, Diane Ehrensperger, Martin Aichinger, Florian Ebner, Nicole Budano, Norbert Schweifer, Martina Sykora, Erik Depla, Joachim Boucneau, Andreas Gschwind, Norbert Kraut, Frank Hilberg and Klaus-Peter Künkele
    Journal of Pharmacology and Experimental Therapeutics March 2023, 384 (3) 331-342; DOI: https://doi.org/10.1124/jpet.122.001255

Behavioral Pharmacology

  • You have access
    Delta Opioid Receptor-Mediated Antidepressant-Like Effects of Diprenorphine in Mice
    Keith M. Olson, Todd M. Hillhouse, Gwendolyn E. Burgess, Joshua L. West, James E. Hallahan, Isaac J. Dripps, Allison G. Ladetto, Kenner C. Rice, Emily M. Jutkiewicz and John R. Traynor
    Journal of Pharmacology and Experimental Therapeutics March 2023, 384 (3) 343-352; DOI: https://doi.org/10.1124/jpet.122.001182
  • You have access
    3,4-Methylenedioxypyrovalerone High-Responder Phenotype as a Tool to Evaluate Candidate Medications for Stimulant Use Disorder
    Michelle R. Doyle, Lindsey N. Peng, Jianjing Cao, Kenner C. Rice, Amy Hauck Newman and Gregory T. Collins
    Journal of Pharmacology and Experimental Therapeutics March 2023, 384 (3) 353-362; DOI: https://doi.org/10.1124/jpet.122.001419
  • You have access
    Attenuation of the Positive-Reinforcing Effects of Ultra-Potent Fentanyl Analogs, Along with Those of Fentanyl and Heroin, During Daily Treatment with Methocinnamox in Rhesus Monkeys
    Lisa R. Gerak and Charles P. France
    Journal of Pharmacology and Experimental Therapeutics March 2023, 384 (3) 363-371; DOI: https://doi.org/10.1124/jpet.122.001267
  • You have access
    The Effects of the Dopamine Transporter Ligands JJC8-088 and JJC8-091 on Cocaine versus Food Choice in Rhesus Monkeys
    Omeed Rahimi, Jianjing Cao, Jenny Lam, Steven R. Childers, Rana Rais, Linda J. Porrino, Amy Hauck Newman and Michael A. Nader
    Journal of Pharmacology and Experimental Therapeutics March 2023, 384 (3) 372-381; DOI: https://doi.org/10.1124/jpet.122.001363

Cardiovascular

  • You have access
    Protein 14-3-3 Influences the Response of the Cardiac Sodium Channel Nav1.5 to Antiarrhythmic Drugs
    Yang Zheng and Isabelle Deschênes
    Journal of Pharmacology and Experimental Therapeutics March 2023, 384 (3) 417-428; DOI: https://doi.org/10.1124/jpet.122.001407

Chemotherapy, Antibiotics, and Gene Therapy

  • Disruption of Ovarian Cancer STAT3 and p38 Signaling with a Small-Molecule Inhibitor of PTP4A3 Phosphatase
    You have access
    Disruption of Ovarian Cancer STAT3 and p38 Signaling with a Small-Molecule Inhibitor of PTP4A3 Phosphatase
    John S. Lazo, Kelly N. Isbell, Sai Ashish Vasa, Danielle C. Llaneza, Ettore J. Rastelli, Peter Wipf and Elizabeth R. Sharlow
    Journal of Pharmacology and Experimental Therapeutics March 2023, 384 (3) 429-438; DOI: https://doi.org/10.1124/jpet.122.001401
  • You have access
    Ocular Administration of Palonosetron in the Prevention of Cisplatin-Induced Nausea and Vomiting
    Jouko Levijoki, Lasse Saloranta, Johanna Tuunainen, Janne Kaskinoro, Sari Pappinen, Sandra Nourry, Anne-Marie Betat, Anne Maurin, Maarit Pakarinen, Sari Häkkinen, Johanna Tervapuro, Hertta Pihlasvaara, Christophe Drieu La Rochelle and Heikki Joensuu
    Journal of Pharmacology and Experimental Therapeutics March 2023, 384 (3) 439-444; DOI: https://doi.org/10.1124/jpet.122.001444

Drug Discovery and Translational Medicine

  • You have access
    The Novel, Clinical-Stage Soluble Guanylate Cyclase Activator BI 685509 Protects from Disease Progression in Models of Renal Injury and Disease
    Glenn A. Reinhart, Paul C. Harrison, Kathleen Lincoln, Hongxing Chen, Peng Sun, Jon Hill, Hu Sheng Qian, Mark C. McHugh, Holly Clifford, Khing Jow Ng, Hong Wang, Danielle Fowler, Kristina Gueneva-Boucheva, Jehrod B. Brenneman, Todd Bosanac, Diane Wong, Ryan M. Fryer, Chris Sarko, Carine M. Boustany-Kari and Steven S. Pullen
    Journal of Pharmacology and Experimental Therapeutics March 2023, 384 (3) 382-392; DOI: https://doi.org/10.1124/jpet.122.001423
  • You have access
    Identification of Glucose Transport Modulators In Vitro and Method for Their Deep Learning Neural Network Behavioral Evaluation in Glucose Transporter 1–Deficient Mice
    Gauri Kathote, Qian Ma, Gustavo Angulo, Hong Chen, Vikram Jakkamsetti, Aksharkumar Dobariya, Levi B. Good, Bruce Posner, Jason Y. Park and Juan M. Pascual
    Journal of Pharmacology and Experimental Therapeutics March 2023, 384 (3) 393-405; DOI: https://doi.org/10.1124/jpet.122.001428
  • You have access
    The Effects of Dual GLP-1/Glucagon Receptor Agonists with Different Receptor Selectivity in Mouse Models of Obesity and Nonalcoholic Steatohepatitis
    Ashref Kayed, Simone Anna Melander, Suheb Khan, Kim Vietz Andreassen, Morten Asser Karsdal and Kim Henriksen
    Journal of Pharmacology and Experimental Therapeutics March 2023, 384 (3) 406-416; DOI: https://doi.org/10.1124/jpet.122.001440

Gastrointestinal, Hepatic, Pulmonary, and Renal

  • You have access
    Neutralizing MIP3α Reduces Renal Immune Cell Infiltration and Progressive Renal Injury in Young Obese Dahl Salt-Sensitive Rats
    Ubong S. Ekperikpe, Bibek Poudel, Corbin A. Shields, Sautan Mandal, Denise C. Cornelius and Jan M. Williams
    Journal of Pharmacology and Experimental Therapeutics March 2023, 384 (3) 445-454; DOI: https://doi.org/10.1124/jpet.122.001298

Inflammation, Immunopharmacology, and Asthma

  • You have access
    Pharmacokinetic/Pharmacodynamic Modeling of Dexamethasone Anti-Inflammatory and Immunomodulatory Effects in LPS-Challenged Rats: A Model for Cytokine Release Syndrome
    Artur Świerczek and William J. Jusko
    Journal of Pharmacology and Experimental Therapeutics March 2023, 384 (3) 455-472; DOI: https://doi.org/10.1124/jpet.122.001477
Back to top
PreviousNext

In this issue

Journal of Pharmacology and Experimental Therapeutics: 384 (3)
Journal of Pharmacology and Experimental Therapeutics
Vol. 384, Issue 3
1 Mar 2023
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts

Jump to

  • Viewpoint
  • Behavioral Pharmacology
  • Cardiovascular
  • Chemotherapy, Antibiotics, and Gene Therapy
  • Drug Discovery and Translational Medicine
  • Gastrointestinal, Hepatic, Pulmonary, and Renal
  • Inflammation, Immunopharmacology, and Asthma
  • Most Cited
  • Most Read
Loading
  • Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians.
  • Functional Selectivity and Classical Concepts of Quantitative Pharmacology
  • Abl Protein-Tyrosine Kinase Inhibitor STI571 Inhibits In Vitro Signal Transduction Mediated by c-Kit and Platelet-Derived Growth Factor Receptors
  • The Prediction of Human Pharmacokinetic Parameters from Preclinical and In Vitro Metabolism Data
  • A METHOD FOR DETERMINING LOSS OF PAIN SENSATION
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics